Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.

Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group.

N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725.

PMID:
31553834
2.

Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sample.

Skrebinska S, Daugule I, Santare D, Isajevs S, Liepniece-Karele I, Rudzite D, Kikuste I, Vanags A, Tolmanis I, Atstupens J, Park JY, Herrero R, Leja M.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):777-783. doi: 10.1080/00365521.2018.1476909. Epub 2018 Jun 11.

PMID:
29889002
3.

Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.

Sjomina O, Pavlova J, Daugule I, Janovic P, Kikuste I, Vanags A, Tolmanis I, Rudzite D, Polaka I, Kojalo I, Liepniece-Karele I, Isajevs S, Santare D, Pirags V, Pahomova J, Dzerve V, Tzivian L, Erglis A, Leja M.

J Gastrointestin Liver Dis. 2018 Mar;27(1):11-17. doi: 10.15403/jgld.2014.1121.271.pep.

4.

Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.

Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS.

Helicobacter. 2017 Aug;22(4). doi: 10.1111/hel.12393. Epub 2017 May 29.

5.

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules.

Nakhleh MK, Amal H, Jeries R, Broza YY, Aboud M, Gharra A, Ivgi H, Khatib S, Badarneh S, Har-Shai L, Glass-Marmor L, Lejbkowicz I, Miller A, Badarny S, Winer R, Finberg J, Cohen-Kaminsky S, Perros F, Montani D, Girerd B, Garcia G, Simonneau G, Nakhoul F, Baram S, Salim R, Hakim M, Gruber M, Ronen O, Marshak T, Doweck I, Nativ O, Bahouth Z, Shi DY, Zhang W, Hua QL, Pan YY, Tao L, Liu H, Karban A, Koifman E, Rainis T, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Tolmanis I, Johnson D, Millstone SZ, Fulton J, Wells JW, Wilf LH, Humbert M, Leja M, Peled N, Haick H.

ACS Nano. 2017 Jan 24;11(1):112-125. doi: 10.1021/acsnano.6b04930. Epub 2016 Dec 21.

6.

Analysis of the effects of microbiome-related confounding factors on the reproducibility of the volatolomic test.

Leja M, Amal H, Lasina I, Skapars R, Sivins A, Ancans G, Tolmanis I, Vanags A, Kupcinskas J, Ramonaite R, Khatib S, Bdarneh S, Natour R, Ashkar A, Haick H.

J Breath Res. 2016 Jun 24;10(3):037101. doi: 10.1088/1752-7155/10/3/037101.

PMID:
27341527
7.

Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations - a randomized trial in Latvia.

Santare D, Kojalo I, Liepniece-Karele I, Kikuste I, Tolmanis I, Polaka I, Vikmanis U, Boka V, Leja M.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):904-10. doi: 10.1097/MEG.0000000000000650.

PMID:
27120388
8.

Emerging blood-based biomarkers for detection of gastric cancer.

Kalniņa Z, Meistere I, Kikuste I, Tolmanis I, Zayakin P, Linē A.

World J Gastroenterol. 2015 Nov 7;21(41):11636-53. doi: 10.3748/wjg.v21.i41.11636. Review.

9.

Breath testing as potential colorectal cancer screening tool.

Amal H, Leja M, Funka K, Lasina I, Skapars R, Sivins A, Ancans G, Kikuste I, Vanags A, Tolmanis I, Kirsners A, Kupcinskas L, Haick H.

Int J Cancer. 2016 Jan 1;138(1):229-36. doi: 10.1002/ijc.29701. Epub 2015 Aug 7.

10.

Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.

Leja M, Lapina S, Polaka I, Rudzite D, Vilkoite I, Daugule I, Belkovets A, Pimanov S, Makarenko J, Tolmanis I, Lejnieks A, Boka V, Rumba-Rozenfelde I, Vikmanis U.

Medicina (Kaunas). 2014;50(1):8-13. doi: 10.1016/j.medici.2014.05.001. Epub 2014 Jun 5.

11.

The effect of incisura angularis biopsy sampling on the assessment of gastritis stage.

Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Funka K, Kikuste I, Vanags A, Tolmanis I, Leja M.

Eur J Gastroenterol Hepatol. 2014 May;26(5):510-3. doi: 10.1097/MEG.0000000000000082.

PMID:
24625520
12.

Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems.

Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K, Kikuste I, Vanags A, Tolmanis I, Leja M.

Virchows Arch. 2014 Apr;464(4):403-7. doi: 10.1007/s00428-014-1544-3. Epub 2014 Jan 30.

PMID:
24477629
13.

Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy.

Leja M, Funka K, Janciauskas D, Putnins V, Ruskule A, Kikuste I, Kojalo U, Tolmanis I, Misins J, Purmalis K, Pimanov S, Makarenko J, Kupcinskas L, Vikmanis U.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):694-9. doi: 10.1097/MEG.0b013e32835e3397.

PMID:
23337173
14.

Performance of routine Helicobacter pylori tests in patients with atrophic gastritis.

Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I, Engstrand L, Janciauskas D, Jonaitis L, Kiudelis G, Kupcinskas L, Ivanauskas A, Leja M.

J Gastrointestin Liver Dis. 2011 Dec;20(4):349-54.

15.

Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage.

Daugule I, Sudraba A, Chiu HM, Funka K, Ivanauskas A, Janciauskas D, Jonaitis L, Kiudelis G, Tolmanis I, Vanags A, Lin JT, Kupcinskas L, Leja M.

Eur J Gastroenterol Hepatol. 2011 Apr;23(4):302-7. doi: 10.1097/MEG.0b013e3283438ac3.

PMID:
21389862
16.

Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.

Jonaitis L, Ivanauskas A, Janciauskas D, Funka K, Sudraba A, Tolmanis I, Krams A, Stirna D, Vanags A, Kupcinskas L, Leja M, Lin JT.

Medicina (Kaunas). 2007;43(8):623-9.

Supplemental Content

Loading ...
Support Center